FDAnews
www.fdanews.com/articles/72246-spherics-secures-26-4-million-financing-to-advance-clinical-programs

Spherics Secures $26.4 Million Financing to Advance Clinical Programs

May 12, 2005

Spherics, Inc., an emerging pharmaceutical company focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles, announced that it has successfully completed its Series C round of financing, raising $26.4 million. The proceeds from this financing will be used to advance the company's pipeline of products based on its proprietary drug delivery technologies, as well as enhance its commercialization and business development capabilities.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050512005109&newsLang=en)